Eli Lilly 2015 Annual Report Download - page 59
Download and view the complete annual report
Please find page 59 of the 2015 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49 -
50 -
51 -
52 -
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62 -
63 -
64 -
65 -
66 -
67 -
68 -
69 -
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
 |
 |
F47
FINANCIAL REPORT
Consolidated Balance Sheets
ELI LILLY AND COMPANY AND SUBSIDIARIES
(Dollars in millions, shares in thousands) December 31 2015 2014
Assets
Current Assets
Cash and cash equivalents (Note 7) $ 3,666.4 $ 3,871.6
Short-term investments (Note 7) 785.4 955.4
Accounts receivable, net of allowances of $44.3 (2015) and $55.0 (2014) 3,513.0 3,234.6
Other receivables 558.6 566.7
Inventories (Note 6) 3,445.8 2,740.0
Prepaid expenses and other 604.4 560.0
Total current assets 12,573.6 11,928.3
Other Assets
Restricted cash (Note 3) —5,405.6
Investments (Note 7) 3,646.6 4,568.9
Goodwill (Note 8) 4,039.9 1,758.1
Other intangibles, net (Note 8) 5,034.8 2,884.2
Sundry 2,220.5 1,798.6
Total other assets 14,941.8 16,415.4
Property and equipment, net (Note 9) 8,053.5 7,963.9
Total assets $ 35,568.9 $ 36,307.6
Liabilities and Equity
Current Liabilities
Short-term borrowings and current maturities of long-term debt (Note 10) $ 6.1 $ 2,688.7
Accounts payable 1,338.2 1,128.1
Employee compensation 967.0 759.0
Sales rebates and discounts 2,560.1 2,068.8
Dividends payable 539.0 530.3
Income taxes payable (Note 13) 358.9 93.5
Other current liabilities 2,460.3 2,472.6
Total current liabilities 8,229.6 9,741.0
Other Liabilities
Long-term debt (Note 10) 7,972.4 5,332.8
Accrued retirement benefits (Note 14) 2,160.3 2,562.9
Long-term income taxes payable (Note 13) 868.9 998.5
Other noncurrent liabilities 1,747.4 2,284.3
Total other liabilities 12,749.0 11,178.5
Commitments and Contingencies (Note 15)
Eli Lilly and Company Shareholders' Equity (Notes 11 and 12)
Common stock—no par value
Authorized shares: 3,200,000
Issued shares: 1,106,063 (2015) and 1,111,437 (2014) 691.3 694.6
Additional paid-in capital 5,552.1 5,292.3
Retained earnings 16,011.8 16,482.7
Employee benefit trust (3,013.2) (3,013.2)
Accumulated other comprehensive loss (Note 16) (4,580.7) (3,991.8)
Cost of common stock in treasury (90.0) (91.4)
Total Eli Lilly and Company shareholders' equity 14,571.3 15,373.2
Noncontrolling interests 19.0 14.9
Total equity 14,590.3 15,388.1
Total liabilities and equity $ 35,568.9 $ 36,307.6
See notes to consolidated financial statements.
Consolidated Balance Sheets